Position in PFE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$12,076,120
-$2,205,368 QoQ
Shares Held
501,500
-1.4% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#376
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GABELLI FUNDS LLC holds $287,466,952 across 14 Drug Manufacturers - General names. PFE ranks #8 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
104,112 | $124,875,066 | |
| 2 | MRK |
Merck & Co., Inc.
|
288,700 | $37,097,950 | |
| 3 | JNJ |
Johnson & Johnson
|
127,317 | $32,334,698 | |
| 4 | AMGN |
Amgen Inc
|
55,700 | $20,170,084 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
256,790 | $14,796,239 | |
| 6 | ABBV |
AbbVie Inc.
|
53,250 | $13,399,830 | |
| 7 | OGN |
Organon & Co.
|
954,910 | $12,929,481 | |
| 8 | PFE |
Pfizer Inc
This page
|
501,500 | $12,076,120 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,076,120 | 501,500 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $14,281,488 | 508,600 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $14,354,850 | 576,500 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $14,941,472 | 586,400 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $13,901,640 | 573,500 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $26,377,039 | 1,040,925 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $27,318,604 | 1,029,725 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $29,123,769 | 1,006,350 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $20,764,321 | 742,113 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $19,713,960 | 710,413 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $16,617,962 | 577,213 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $19,899,114 | 599,913 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $22,107,512 | 602,713 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $24,564,170 | 602,063 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $30,611,442 | 597,413 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $26,149,356 | 597,563 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $31,581,892 | 602,363 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $30,933,248 | 597,513 | Shares | Sole | 2022-05-18 | |
| 2021-12-31 | $35,383,527 | 599,213 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $26,761,381 | 622,213 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $20,719,086 | 529,088 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $19,331,893 | 533,588 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $19,788,614 | 537,588 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $19,802,860 | 539,588 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $17,840,746 | 545,588 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $22,675,760 | 694,724 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||